Psychedelic Drugs Market Players:
- Compass Pathways Plc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Mind Medicine Inc.
- Jazz Pharmaceuticals plc
- Johnson & Johnson Pte. Ltd.
- Hikma Pharmaceuticals PLC
- Thoughtful Brands Inc.
- Pfizer Inc.
- F. Hoffmann-La Roche AG
- Avadel Pharmaceuticals plc
- NRx Pharmaceuricals, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of psychedelic drugs is assessed at USD 3.96 billion.
The global psychedelic drugs market size surpassed USD 3.54 billion in 2025 and is projected to witness a CAGR of over 13.3%, crossing USD 12.34 billion revenue by 2035.
North America psychedelic drugs market will hold around 40% share by 2035, driven by rising government initiatives to promote mental health awareness.
Key players in the market include Compass Pathways Plc., Mind Medicine Inc., Jazz Pharmaceuticals plc, Johnson & Johnson Pte. Ltd., Hikma Pharmaceuticals PLC, Thoughtful Brands Inc., Pfizer Inc., F. Hoffmann-La Roche AG, Avadel Pharmaceuticals plc, NRx Pharmaceuricals, Inc.
